-
Published 6/29/2026
Soman P, Clerc OF, Gimelli A, Malhotra S, Pandey S, Shah NR, Sperry BW. Corrigendum to "The evolution of Tc-99m-labeled cardiac amyloid radionuclide imaging for transthyretin cardiomyopathy: Current state-of-the-art" [J Nucl Cardiol 59(S) (2026) 102735]. J Nucl Cardiol. 2026 Jun 29; 102768. PMID: 42373413.
-
Published 5/15/2026
Soman P, Clerc O, Gimelli A, Malhotra S, Pandey S, Shah N, Sperry B. The evolution of Tc-99m- labeled cardiac amyloid radionuclide imaging for transthyretin cardiomyopathy: Current state-of-the-art. J Nucl Cardiol. 2026 May; 59S:102735. PMID: 42142950.
-
Published 2/1/2026
Pandey S, Ruberg FL. A tale of two tracers-does one outperform the other? J Nucl Cardiol. 2026 Feb; 56:102621. PMID: 41771626.
-
Published 10/1/2025
Ruberg FL, Teruya S, Helmke S, Smiley DA, Fine D, Kurian D, Raiszadeh F, Prokaeva T, Spencer B, Wong S, Pandey S, Blaner WS, DeLuca A, Johnson LL, Kinkhabwala MP, Leb J, Mintz A, LaValley MP, Einstein AJ, Cohn E, Gallegos C, Murtagh G, Kelly JW, Miller EJ, Maurer MS. Transthyretin Cardiac Amyloidosis in Older Black and Hispanic Individuals With Heart Failure. JAMA Cardiol. 2025 Oct 01; 10(10):1034-1043. PMID: 40928765.
-
Published 9/1/2025
Pandey S. The case for serial quantitative cardiac amyloid radionuclide imaging - will nuclear cardiology continue to transform care in transthyretin cardiac amyloidosis? J Nucl Cardiol. 2025 Sep; 51:102446. PMID: 40973356.